Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1-OH-midazolam in morbidly obese and weight loss surgery patients.

CPT Pharmacometrics Syst Pharmacol · 2016 · PMC4728292 · PMID 26844012

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

showed a trendP > 0.05actually significant

In addition, intrinsic midazolam gut wall clearance (CL int,G ) showed a trend toward lower values in patients after surgery ( P > 0.05).

also in 33,226 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.